SCHEMBL10061664

SCHEMBL10061664

C=C1C(=O)Nc2ccc(C(=O)OC)cc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.55
AURKA O14965 1/20 0.54
RAF1 P04049 1/20 0.54
ALDH1A1 P00352 4/20 0.45
LMNA P02545 1/20 0.45
CASP3 P42574 1/20 0.44
KMT2A Q03164 2/20 0.44
CTDSP1 Q9GZU7 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
XDH P47989 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44
ALOX5 P09917 1/20 0.43
PTPRC P08575 1/20 0.42
CCNB2 O95067 1/20 0.42
CDK1 P06493 1/20 0.42
CCNB1 P14635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15784421 0.88 ALDH1A1 (0.48) PDPK1AURKARAF1ALDH1A1LMNA
SCHEMBL22380701 0.84 PDPK1 (0.57) PDPK1AURKARAF1ALDH1A1LMNA
SCHEMBL10061665 0.82 FCER2 (0.44) PDPK1CRBNPDK2
SCHEMBL13712805 0.81 SMYD3 (0.45) ALDH1A1KMT2AXDHMEN1CREBBP
SCHEMBL10061663 0.81 TLK2 (0.51) PDPK1KMT2ACA12CA2CA7
SCHEMBL3052163 0.79 PDPK1 (0.53) PDPK1AURKARAF1ALDH1A1LMNA
Anisole SCHEMBL28074863 0.79 TDP1 (0.44) PDPK1ALDH1A1LMNAKMT2ACTDSP1
SCHEMBL23252156 0.77 PDPK1 (0.51) PDPK1AURKARAF1ALDH1A1LMNA
SCHEMBL5894610 0.77 PDPK1 (0.63) PDPK1AURKARAF1ALDH1A1KMT2A
SCHEMBL5894451 0.77 PDPK1 (0.63) PDPK1AURKARAF1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207179-B2 Substituted indolines as tyrosine kinase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-26 US disclosed
US-20100222331-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222331-A1 NEW COMPOUNDS CCNA1, CCNY, MKI67 PDPK1 1543/4885AURKA 1486/4885RAF1 540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.